Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost for optic disc drusen
ACTRN12619001464156Phase 4Completed
- Sponsor
- Jesse Gale
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of latanoprost in optic disc drusen (ODD), sponsored by Jesse Gale. Primary endpoints: Photopic negative response ratio and Pattern electroretinogram ratio. Started Dec 2019; status: completed.
02
Drugs
latanoprost
03
Conditions
optic disc drusen (ODD)
Beyond the preview
Go deeper on ACTRN12619001464156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001464156.